| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.2 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |